A mediastinal mass is an abnormal growth in the mediastinum, the central compartment of your chest between the lungs. This area houses some of your most vital structures: the heart, major blood vessels, trachea (windpipe), esophagus, and thymus gland. Masses here can be benign or malignant, and the location within the mediastinum often points toward the likely cause.
Where the Mediastinum Is and Why Location Matters
The mediastinum runs from the top of your chest (just above the collarbones) down to the diaphragm. It sits between the two lungs and is divided into three compartments, each containing different organs. When a mass shows up on imaging, the compartment it occupies is one of the first clues to what it might be.
The anterior compartment sits behind the breastbone and in front of the heart’s protective sac (the pericardium). The thymus gland lives here. The middle compartment is essentially the pericardial space, containing the heart, the roots of the major blood vessels, the trachea, and the main bronchi. The posterior compartment runs along the spine behind the heart, and the esophagus passes through it. About 50% of all mediastinal masses occur in the anterior compartment.
Common Causes by Compartment
Anterior mediastinal masses are often remembered by doctors using the “4 Ts”: thymoma (a tumor of the thymus gland), teratoma (a type of germ cell tumor), thyroid tissue that has grown downward into the chest, and lymphoma (sometimes called “terrible lymphoma” to fit the mnemonic). These four account for the majority of growths found in the front of the mediastinum.
Masses in the middle mediastinum are most commonly congenital cysts, meaning fluid-filled sacs that formed during development. Bronchogenic cysts, which develop from airway tissue, are a typical example. In the posterior mediastinum, neurogenic tumors dominate. These arise from nerve tissue along the spine and include schwannomas and tumors of the sympathetic nerve chain.
Symptoms and What They Mean
Many mediastinal masses produce no symptoms at all and are discovered incidentally on a chest X-ray or CT scan done for another reason. When symptoms do occur, they’re usually caused by the mass pressing on nearby structures rather than the mass itself being painful.
A mass pushing on the trachea or bronchi can cause a persistent cough, wheezing, or shortness of breath. If it compresses the esophagus, swallowing may become difficult. One of the more serious complications is compression of the superior vena cava, the large vein that returns blood from your upper body to the heart. This can cause swelling in the face, neck, and arms, along with visible distension of veins in the chest. Posterior masses near the spine can occasionally cause back pain or, in rare cases, nerve-related symptoms like weakness or numbness.
How a Mediastinal Mass Is Diagnosed
A contrast-enhanced CT scan is the primary tool for identifying and characterizing mediastinal masses. CT is fast, widely available, and provides excellent detail of the structures in the chest. It can often distinguish solid tumors from fluid-filled cysts and show the relationship between the mass and surrounding organs.
When CT results are inconclusive, MRI is the preferred next step. MRI is particularly useful for detecting subtle features like microscopic fat within a mass, internal nodularity, or fine soft tissue detail that CT may miss. PET scans, which detect metabolically active tissue, play a more limited role in evaluating cystic masses but can help determine whether a solid mass is likely cancerous.
Getting a tissue sample is often necessary for a definitive diagnosis. Current guidelines recommend starting with minimally invasive ultrasound-guided needle biopsy rather than jumping to surgery. The two main approaches are passing a needle through the airway wall (using a specialized bronchoscope with ultrasound) or through the esophageal wall. These techniques have a diagnostic accuracy comparable to surgical biopsy but with less risk and faster recovery. If the needle biopsy results are inconclusive or don’t match what imaging suggests, a surgical biopsy through a small incision at the base of the neck (mediastinoscopy) or a camera-assisted procedure through the chest wall may follow.
Benign vs. Malignant Masses
Not all mediastinal masses are cancer. Cysts, benign thyroid growths, and certain neurogenic tumors are entirely noncancerous. However, the overall malignancy rate is high. In one study of both children and adults with primary mediastinal tumors, 81% of pediatric masses and 90% of adult masses were malignant. These numbers likely reflect referral patterns at surgical centers, where benign masses that don’t need treatment are underrepresented. Still, the statistics underscore why mediastinal masses are taken seriously and investigated promptly.
Treatment Options
Treatment depends entirely on what the mass is. Simple cysts that cause no symptoms may only need monitoring. Cancers like lymphoma are typically treated with chemotherapy, sometimes combined with radiation, rather than surgery. Solid tumors like thymomas, teratomas, and neurogenic tumors usually require surgical removal.
Surgical approaches have evolved considerably. For decades, removing a mediastinal mass meant a large incision through the breastbone (sternotomy) or between the ribs (thoracotomy), with significant recovery time and surgical trauma. Minimally invasive techniques have largely replaced these open procedures. Video-assisted thoracic surgery (VATS) uses small incisions and a camera, resulting in less blood loss, less chest tube drainage, and shorter hospital stays compared to open surgery.
Robotic-assisted surgery has taken this a step further. Robotic systems offer a high-definition, three-dimensional view with up to 10 times magnification and instruments that bend with greater range of motion than human hands. The first robotic thymectomy was performed in 2001, and the technique has since been adopted worldwide. The surgical team positions you differently depending on where the tumor sits: on your side for posterior masses, semi-reclined for anterior masses, or in a head-up tilt for thymus removal. Recovery from robotic and VATS procedures is faster than open surgery, with shorter hospital stays and fewer complications.
Recurrence After Removal
For thymomas, one of the most common surgically treated mediastinal masses, the overall recurrence rate after complete removal is about 13%. The risk varies widely depending on the tumor’s characteristics. The least aggressive types (type A) have a 0% recurrence rate, while the most aggressive (type B3) recur in roughly 21% of cases. Stage also matters: early-stage thymomas recur about 6% of the time, while advanced-stage tumors recur in up to 50% of cases. Long-term follow-up with periodic imaging is standard after any thymoma resection, and treatment of thymic cancers in particular benefits from a multidisciplinary team with experience in these relatively uncommon tumors.